Status:
COMPLETED
Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
Lead Sponsor:
Princess Nourah Bint Abdulrahman University
Conditions:
Anosmia
Ageusia
Eligibility:
All Genders
12-65 years
Brief Summary
COVID-19 has adversely affected the healthcare system across the world. The world was not prepared for global outbreak of infectious diseases. The rapid spread of severe acute respiratory syndrome cor...
Detailed Description
Upon identification of the patient in the triage area the research assistant will start the study by introducing the concept for the patient and then taking consent. The patient will go through the re...
Eligibility Criteria
Inclusion
- 1- Suspected cases of COVID -19 fulfilling the case definition of Saudi CDC 2- Adult patients
- \-
Exclusion
- The cases of children under the age of 12 years
- Known patients with Kallmann's syndrome, CHARGE syndrome, Indifference to pain syndrome, ciliopathy disorders.
- Known patient with congenital anomalies, absent smell sense, and absent taste sense.
- Pregnant and lactating ladies
- Patients with trigeminal nerve disease
- Blind and deaf patients
- Malingering.
- Adults aged more than 65 years old.
- Allergy to quinine products
- \-
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04388618
Start Date
June 15 2020
End Date
December 31 2021
Last Update
May 4 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Nourah Bint Abdulrahman Univeristy
Riyadh, Central, Saudi Arabia, 11552
2
prince Mohammed bin Abdulaziz Hospital
Riyadh, Central, Saudi Arabia